Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
The FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Separately, FDA employees got an email Monday from Sara Brenner, the FDA's acting commissioner, that Kyle Diamantas, a lawyer ...
An industry source said “most, if not all” of the people at CDRH who were recently dismissed are now being asked to return.
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
A number of agencies are looking to rehire federal workers who lost their jobs as part of the Trump administration's mission ...
The reversal is the latest example of President Donald Trump and billionaire Elon Musk's chaotic approach to cost-cutting, ...
Early in the new year, the US Food and Drug Administration (FDA) released two anticipated draft guidance documents focused on artificial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback